Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma

被引：0
|
作者：
E. Herrmann
N. Marschner
M. O. Grimm
C. H. Ohlmann
U. Hutzschenreuter
F. Overkamp
M. Groschek
K. Blumenstengel
G. Pühse
T. Steiner
机构：
[1] University of Münster,Department of Urology
[2] Medical Practice for Oncology and Hematology,Department of Urology
[3] University of Dresden,Department of Urology
[4] University of the Saarland,Department of Urology
[5] Medical Practice for Oncology and Hematology,undefined
[6] Medical Practice for Oncology and Hematology,undefined
[7] Medical Practice for Oncology and Hematology,undefined
[8] Medical Practice for Oncology and Hematology,undefined
[9] University Hospital Jena,undefined
来源：
World Journal of Urology | 2011年 / 29卷
关键词：
Sorafenib; Sunitinib; Renal cell carcinoma; Sequential therapies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：361 / 366
页数：5
相关论文
共 50 条
  • [1] Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma
    Herrmann, E.
    Marschner, N.
    Grimm, M. O.
    Ohlmann, C. H.
    Hutzschenreuter, U.
    Overkamp, F.
    Groschek, M.
    Blumenstengel, K.
    Puehse, G.
    Steiner, T.
    WORLD JOURNAL OF UROLOGY, 2011, 29 (03) : 361 - 366
  • [2] Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma.
    Herrmann, E.
    Marschner, N.
    Grimm, M.
    Ohlmann, C. H.
    Hutzschenreuther, U.
    Overkamp, F.
    Groschek, M.
    Blumenstengel, K.
    Steiner, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma
    Stenner, Frank
    Chastonay, Rahel
    Liewen, Heike
    Haile, Sarah R.
    Cathomas, Richard
    Rothermundt, Christian
    Siciliano, Raffaele D.
    Stoll, Susanna
    Knuth, Alexander
    Buchler, Tomas
    Porta, Camillo
    Renner, Christoph
    Samaras, Panagiotis
    ONCOLOGY, 2012, 82 (06) : 333 - 340
  • [4] Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
    Sablin, M. P.
    Negrier, S.
    Ravaud, A.
    Oudard, S.
    Balleyguier, C.
    Gautier, J.
    Celier, C.
    Medioni, J.
    Escudier, B.
    JOURNAL OF UROLOGY, 2009, 182 (01): : 29 - 34
  • [5] Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
    Schlemmer, Marcus
    Spek, Annabel
    Rodler, Severin
    Schott, Melanie
    Casuscelli, Jozefina
    Staehler, Michael
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (03)
  • [6] Efficacy of sequential therapies with sorafenib-sunitinib versus sunitinib-sorafenib in metastatic renal cell carcinoma: A systematic review and meta-analysis
    Wen, Tingyu
    Xiao, Hai
    Luo, Chao
    Huang, Li
    Xiong, Meimei
    ONCOTARGET, 2017, 8 (12) : 20441 - 20451
  • [7] Re: Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
    Di Lorenzo, Giuseppe
    Autorino, Riccardo
    JOURNAL OF UROLOGY, 2010, 183 (02): : 824 - 825
  • [8] Sequential Therapy With Sorafenib and Sunitinib in Renal Cell Carcinoma
    Dudek, Arkadiusz Z.
    Zolnierek, Jakub
    Dham, Anu
    Lindgren, Bruce R.
    Szczylik, Cezary
    CANCER, 2009, 115 (01) : 61 - 67
  • [9] Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
    Dham, A.
    Dudek, A. Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] SEQUENTIAL TARGET THERAPY FOR METASTATIC RENAL CELL CARCINOMA: COMPARISON OF SUNITINIB+SORAFENIB VS. SORAFENIB+SUNITINIB
    Antonelli, Alessandro
    Daja, Julian
    Ferrari, Vittorio
    Arrighi, Nicola
    Cunico, Sergio Cosciani
    Simeone, Claudio
    ANTICANCER RESEARCH, 2011, 31 (05) : 1922 - 1923
12345